| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/16/1999 | US5882655 Serpulina hyodysenteriae vaccine comprising a hygene mutant |
| 03/16/1999 | US5882654 Polyvalent melanoma vaccine |
| 03/16/1999 | US5882652 Empty canine parvovirus capsids having CPV recombinant VP2 and vaccines having such capsids |
| 03/16/1999 | US5882651 Attenuated respiratory syncytial virus vaccine compositions |
| 03/16/1999 | US5882650 Influenza a virus ns1 protein, or a t cell epitope thereof, is administered to the individual in an amount sufficient to stimulate the virus protective response |
| 03/16/1999 | US5882649 Presentation of antigens to the mucosal immune system. |
| 03/16/1999 | US5882645 Peptide compounds |
| 03/16/1999 | US5882643 Identification and characterization of such factors which can play a role in preventing, ameliorating or correcting infections, dysfunctions or diseases. a novel lep gene of streptococcus pneumoniae. |
| 03/16/1999 | CA2244232A1 Novel def |
| 03/16/1999 | CA2236363A1 Novel compound |
| 03/16/1999 | CA2090186C Method of treatment of hiv-seropositive individuals with dietary whey proteins |
| 03/16/1999 | CA2086831C Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them |
| 03/16/1999 | CA1340446C Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen |
| 03/16/1999 | CA1340431C Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor |
| 03/11/1999 | WO1999012038A1 Detection of measles virus-specific antibodies |
| 03/11/1999 | WO1999012037A1 Compositions and methods for the treatment of inflammatory bowel disease |
| 03/11/1999 | WO1999011809A1 Conjugates that contain the homeodomain of antennapedia |
| 03/11/1999 | WO1999011808A1 Rna respiratory syncytial virus vaccines |
| 03/11/1999 | WO1999011798A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells |
| 03/11/1999 | WO1999011788A1 Kringle1 |
| 03/11/1999 | WO1999011782A1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof |
| 03/11/1999 | WO1999011762A1 An attenuated japanese encephalitis virus adapted to vero cell and a japanese encephalitis vaccine |
| 03/11/1999 | WO1999011753A1 SpoOJ2 OF STAPHYLOCOCCUS AUREUS |
| 03/11/1999 | WO1999011667A1 METHYLATED, SmD HOMOLOGOUS PEPTIDES, REACTIVE WITH THE ANTIBODIES FROM SERA OF LIVING BEINGS AFFECTED WITH SYSTEMIC LUPUS ERYTHEMATOSUS |
| 03/11/1999 | WO1999011661A1 Biomolecules comprising an elastomeric peptide |
| 03/11/1999 | WO1999011660A2 Immunogenic polypeptides that mimic a surface polysaccharide antigen of a pathogenic microorganism, method for obtaining the same, and their use in vaccine compositions |
| 03/11/1999 | WO1999011286A1 Vaginal suppository vaccine for urogenital infections |
| 03/11/1999 | WO1999011285A1 Composition to protect a mammal against bartonella henselae infection |
| 03/11/1999 | WO1999011283A1 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase |
| 03/11/1999 | WO1999011275A2 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation |
| 03/11/1999 | WO1999011263A1 Combination therapy comprising amlodipine and a statin compound |
| 03/11/1999 | WO1999011259A1 Therapeutic combinations comprising amlodipin and atorvastatin |
| 03/11/1999 | WO1999011247A1 Biphasic lipid vesicle composition for transdermal administration of an immunogen |
| 03/11/1999 | WO1999011241A1 Oil in water emulsions containing saponins |
| 03/11/1999 | WO1998057981A3 Chlamydia pneumoniae specific peptides and their use in diagnostic assays |
| 03/11/1999 | WO1998044788A3 Animal model for evaluation of vaccines |
| 03/11/1999 | WO1998042847A3 Papilloma virus main capsid protein and the use thereof in diagnosis, therapy and vaccination |
| 03/11/1999 | DE19739685A1 Monoklonale Antikörper zur Therapie und Prophylaxe von Erkrankungen durch Clostridium difficile Monoclonal antibodies for the therapy and prophylaxis of diseases caused by Clostridium difficile |
| 03/11/1999 | CA2302805A1 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation |
| 03/11/1999 | CA2302505A1 Vaginal suppository vaccine for urogenital infections |
| 03/11/1999 | CA2302494A1 Biphasic lipid vesicle composition for transdermal administration of an immunogen |
| 03/11/1999 | CA2302168A1 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase |
| 03/11/1999 | CA2301981A1 Biomolecules comprising an elastomeric peptide |
| 03/11/1999 | CA2301157A1 Conjugates that contain the homeodomain of antennapedia |
| 03/11/1999 | CA2296758A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells |
| 03/10/1999 | EP0900848A2 MecB polynucleotides and polypeptides from the Clpc ATPase family of Stapyloccoccus aureus |
| 03/10/1999 | EP0900847A2 Phosphoribosyl transferase from Staphylococcus aureus |
| 03/10/1999 | EP0900846A2 Nucleic acid encoding Streptococcus pneumoniae response regulator |
| 03/10/1999 | EP0900845A2 Signal recognition particle polypeptides and polynucleotides |
| 03/10/1999 | EP0900844A2 Membrane protein of Staphylococcus aureus |
| 03/10/1999 | EP0900843A2 FfH polypeptide from Streptococcus |
| 03/10/1999 | EP0900841A1 LAG-3 splice variants |
| 03/10/1999 | EP0900380A1 Methods for selecting and producing t cell peptide epitopes and vaccines incorporating said selected epitopes |
| 03/10/1999 | EP0900275A1 Methods and reagents for modulating apoptosis |
| 03/10/1999 | EP0900232A1 High molecular weight surface proteins of non-typeable haemophilus |
| 03/10/1999 | EP0900231A1 Flea protease proteins, nucleic acid molecules, and uses thereof |
| 03/10/1999 | EP0900229A1 Novel compounds |
| 03/10/1999 | EP0900089A1 Biological material free of viral and molecular pathogens and a process for the production thereof |
| 03/10/1999 | EP0900087A1 Process for disintegrating nucleic acids and preparing biological products of guaranteed quality |
| 03/10/1999 | EP0900025A1 $i(MORAXELLA CATARRHALIS) OUTER MEMBRANE PROTEIN-106 POLYPEPTIDE, GENE SEQUENCE AND USES THEREOF |
| 03/10/1999 | EP0773951B1 Dinucleoside-5',5'-pyrophosphates |
| 03/10/1999 | EP0735898B1 Vaccines |
| 03/10/1999 | EP0505357B1 Method for antibody targeting of diagnostic or therapeutic agents |
| 03/10/1999 | EP0494158B1 A recombinant birth control vaccine |
| 03/10/1999 | CN1210558A Recombinant phages |
| 03/10/1999 | CN1210470A Vacciness against varicella zoster virus gene 63 product |
| 03/10/1999 | CN1210017A Functional milk for immunization |
| 03/10/1999 | CA2243670A1 Novel histidine kinase |
| 03/09/1999 | US5880268 Modulators of the interaction between ICAM-R and αd /CD18 |
| 03/09/1999 | US5880267 Trophinin and trophinin-assisting protein agonists, antibodies and antagonists |
| 03/09/1999 | US5880263 Human chemotactic protein |
| 03/09/1999 | US5880262 Response regulator polypeptides from streptococcus pneumoniae; for diagnosis of bacterial infections including otitis media and meningitis; for screening of new antibiotics, bactericides |
| 03/09/1999 | US5880104 Administering a plasmid vector encoding a fusion protein lacking a transmembrane region |
| 03/09/1999 | US5880103 Administering to mammal nucleic acid which expresses immunogenic peptide within cell to elicit t-cell mediated immune response |
| 03/09/1999 | US5880095 Cholesteryl ester transfer protein inhibitor peptides and prophylactic and therapeutic anti-arteriosclerosis agents |
| 03/09/1999 | US5879952 43 Kd protein vaccine and method for the production thereof |
| 03/09/1999 | US5879933 Mammalian Retrotransposons |
| 03/09/1999 | US5879925 Genetically engineered human immunodeficiency virus-like particles with modified chimeric envelope glycoproteins containing influenza virus transmembrane spanning domains |
| 03/09/1999 | US5879911 Cell surface protein expressed on human cortical thymocyte and their use |
| 03/09/1999 | US5879908 CRFG-1a, a target and marker for chronic renal failure |
| 03/09/1999 | US5879904 Nucleotide and peptide sequences of a hepatitis C virus isolate, diagnostic and therapeutic applications |
| 03/09/1999 | US5879898 Antibodies specific for peptide corresponding to CD44 exon 6, and use of these antibodies for diagnosis of tumors |
| 03/09/1999 | US5879895 Recombinant bovine herpesvirus type 1 polypeptides and immunoassays |
| 03/09/1999 | US5879712 Introducing solution comprising alginate and drug into mixing chamber to form droplets, introducing stream of emulsifier, forming emulsion, transporting to second mixing chamber, introducing crosslinking agent to form microparticles |
| 03/09/1999 | US5879703 Encapsulation of active ingredients into lipid vesicles |
| 03/09/1999 | US5879687 Enhancing or eliciting cellular and/or humoral immune response, for treating tumors |
| 03/09/1999 | US5879686 Administering refolded trimeric meningococcal group b porin protein-polysaccharide conjugate to raise immune response in animal |
| 03/09/1999 | US5879685 Antigens for influenza |
| 03/09/1999 | US5879683 Antibacterial agent containing tea extract or active fraction thereof and β-lactam antibiotic |
| 03/09/1999 | US5879682 Aframonum seeds for improving penile activity |
| 03/09/1999 | US5879679 Antigen-based heteropolymers and method for treating autoimmune diseases using the same |
| 03/09/1999 | US5879675 Opsonizing tumor cell obtained from animal by incubating in presence of alpha-galactosyl epitope and glycosphingolipids to insert epitope into cell membrane, irradiating cell, administering to animal |
| 03/09/1999 | CA2243656A1 Response regulator |
| 03/09/1999 | CA2105538C Differentially expressed leishmania genes and proteins |
| 03/09/1999 | CA2038279C Cd25 binding molecules |
| 03/09/1999 | CA1340423C Mycobacterial recombinants and peptides |
| 03/04/1999 | WO1999010497A1 Novel mutants of gram negative mucosal bacteria and application thereof in vaccines |
| 03/04/1999 | WO1999010496A1 Tuberculosis vaccine |
| 03/04/1999 | WO1999010494A2 Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses |
| 03/04/1999 | WO1999010492A1 Adipocyte-specific protein homologs |